Literature DB >> 8910220

Absence of Ca2+ current facilitation in skeletal muscle of transgenic mice lacking the type 1 ryanodine receptor.

A Fleig1, H Takeshima, R Penner.   

Abstract

1. Whole-cell patch-clamp recordings were used to study voltage-dependent facilitation of Ca2+ currents and excessive Ca2+ tail current in skeletal myoballs cultured from wild-type and transgenic mice expressing a null mutation of the ryanodine receptor (RyR) type 1 (dyspedic myoballs). 2. Ca2+ current density in dyspedic myoballs was reduced by about 60% compared with wild-type cells, with dihydropyridine-binding capacity largely retained. 3. Strong and long-lasting depolarizations (+80 mV and 600 ms), which normally produce excessive tail currents upon repolarization in control cells, failed to do so in dyspedic myoballs. 4. Dyspedic myoballs also failed to produce both Ca2+ current facilitation and the left shift of the current-voltage (I-V) curve induced by paired-pulse stimulation. 5. We propose that excessive tail currents and facilitation arise from silent Ca2+ channels acting as the voltage sensors in excitation-contraction coupling.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8910220      PMCID: PMC1160881          DOI: 10.1113/jphysiol.1996.sp021689

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  15 in total

Review 1.  DHP receptors and excitation-contraction coupling.

Authors:  G D Lamb
Journal:  J Muscle Res Cell Motil       Date:  1992-08       Impact factor: 2.698

2.  A lethal mutation in mice eliminates the slow calcium current in skeletal muscle cells.

Authors:  K G Beam; C M Knudson; J A Powell
Journal:  Nature       Date:  1986 Mar 13-19       Impact factor: 49.962

3.  Involvement of dihydropyridine receptors in excitation-contraction coupling in skeletal muscle.

Authors:  E Rios; G Brum
Journal:  Nature       Date:  1987 Feb 19-25       Impact factor: 49.962

4.  A possible role of sarcoplasmic Ca2+ release in modulating the slow Ca2+ current of skeletal muscle.

Authors:  D Feldmeyer; W Melzer; B Pohl; P Zöllner
Journal:  Pflugers Arch       Date:  1993-10       Impact factor: 3.657

5.  Voltage dependent charge movement of skeletal muscle: a possible step in excitation-contraction coupling.

Authors:  M F Schneider; W K Chandler
Journal:  Nature       Date:  1973-03-23       Impact factor: 49.962

6.  Voltage-dependent potentiation of L-type Ca2+ channels due to phosphorylation by cAMP-dependent protein kinase.

Authors:  A Sculptoreanu; T Scheuer; W A Catterall
Journal:  Nature       Date:  1993-07-15       Impact factor: 49.962

7.  Dihydropyridine receptors in muscle are voltage-dependent but most are not functional calcium channels.

Authors:  L M Schwartz; E W McCleskey; W Almers
Journal:  Nature       Date:  1985 Apr 25-May 1       Impact factor: 49.962

8.  Silent calcium channels generate excessive tail currents and facilitation of calcium currents in rat skeletal myoballs.

Authors:  A Fleig; R Penner
Journal:  J Physiol       Date:  1996-07-01       Impact factor: 5.182

9.  Requirement of the calcium channel beta subunit for functional conformation.

Authors:  S Nishimura; H Takeshima; F Hofmann; V Flockerzi; K Imoto
Journal:  FEBS Lett       Date:  1993-06-21       Impact factor: 4.124

10.  Excitation-contraction uncoupling and muscular degeneration in mice lacking functional skeletal muscle ryanodine-receptor gene.

Authors:  H Takeshima; M Iino; H Takekura; M Nishi; J Kuno; O Minowa; H Takano; T Noda
Journal:  Nature       Date:  1994-06-16       Impact factor: 49.962

View more
  15 in total

1.  Slow deactivation and U-shaped inactivation properties in cloned Cav1.2b channels in Chinese hamster ovary cells.

Authors:  Masahiro Aoyama; Manabu Murakami; Toshihide Iwashita; Yasushi Ito; Kenichi Yamaki; Shinsuke Nakayama
Journal:  Biophys J       Date:  2003-01       Impact factor: 4.033

2.  Gating of the HypoPP-1 mutations: II. Effects of a calcium-channel agonist BayK 8644.

Authors:  Alexey Kuzmenkin; Chao Hang; Elza Kuzmenkina; Karin Jurkat-Rott
Journal:  Pflugers Arch       Date:  2007-03-01       Impact factor: 3.657

3.  Gating of the HypoPP-1 mutations: I. Mutant-specific effects and cooperativity.

Authors:  Alexey Kuzmenkin; Chao Hang; Elza Kuzmenkina; Karin Jurkat-Rott
Journal:  Pflugers Arch       Date:  2007-02-27       Impact factor: 3.657

4.  Effect of nifedipine on depolarization-induced force responses in skinned skeletal muscle fibres of rat and toad.

Authors:  G S Posterino; G D Lamb
Journal:  J Muscle Res Cell Motil       Date:  1998-01       Impact factor: 2.698

5.  Distinct Components of Retrograde Ca(V)1.1-RyR1 Coupling Revealed by a Lethal Mutation in RyR1.

Authors:  Roger A Bannister; David C Sheridan; Kurt G Beam
Journal:  Biophys J       Date:  2016-02-23       Impact factor: 4.033

6.  Functional impact of the ryanodine receptor on the skeletal muscle L-type Ca(2+) channel.

Authors:  G Avila; R T Dirksen
Journal:  J Gen Physiol       Date:  2000-04       Impact factor: 4.086

7.  Prolonged depolarization promotes fast gating kinetics of L-type Ca2+ channels in mouse skeletal myotubes.

Authors:  K M O'Connell; R T Dirksen
Journal:  J Physiol       Date:  2000-12-15       Impact factor: 5.182

8.  Malignant hyperthermia mutation Arg615Cys in the porcine ryanodine receptor alters voltage dependence of Ca2+ release.

Authors:  B Dietze; J Henke; H M Eichinger; F Lehmann-Horn; W Melzer
Journal:  J Physiol       Date:  2000-08-01       Impact factor: 5.182

Review 9.  Minding the calcium store: Ryanodine receptor activation as a convergent mechanism of PCB toxicity.

Authors:  Isaac N Pessah; Gennady Cherednichenko; Pamela J Lein
Journal:  Pharmacol Ther       Date:  2009-11-25       Impact factor: 12.310

10.  Ryanodine receptor type 2 deficiency changes excitation-contraction coupling and membrane potential in urinary bladder smooth muscle.

Authors:  Shingo Hotta; Kozo Morimura; Susumu Ohya; Katsuhiko Muraki; Hiroshi Takeshima; Yuji Imaizumi
Journal:  J Physiol       Date:  2007-03-15       Impact factor: 5.182

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.